Skip to content
Screener

Exelixis EXEL Europe — Total revenues

Similar metrics at other companies

Salesforce logo
CRMEurope — Total revenues
$2.75B+17.8%
Veeva Systems logo
VEEVEurope — Total revenues
$265.67M+22.4%
Calix logo
CALXEurope — Total revenues
$4.93M-68.3%
GE Vernova logo
GEVEurope — Total revenues
$1.9B-8.8%
comScore logo
SCOREurope — Total revenues
$6.14M+15.6%
FTAI Aviation Ltd. logo
FTAIEurope — Total revenues
$248.31M+45.3%

Other financials

Income statement

See full
Revenue$628.7M+10.6%
Gross profit$608.0M+10.8%
Operating income$248.4M+16.3%
Net income$212.1M+14.7%
EPS (diluted)$0.82+26.2%

Balance sheet

See full
Cash & equivalents$281.4M+71.2%
Total debt$165.9M-7.7%
Total equity$1.8B-9.3%
Total assets$2.5B-6.9%

Cash flow

See full
Operating cash flow$307.7M+528%
CapEx$6.8M+140%
Free cash flow$300.9M+552%

Valuation

See full
Market cap$14.25B+40.4%
Enterprise value$14.14B+39.0%
P/E16.6×-0.3×
P/S5.9×+1.3×

Profitability

See full
Gross margin96.5%-0.1pp
Operating margin39.9%+8.5pp
Net margin35.3%+8.3pp
FCF margin48.1%+14.3pp

Returns & leverage

See full
Return on equity44.4%+15.4pp
Debt / equity0.1×0.0×
Current ratio3.5×-0.1×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Exelixis’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0000939767-26-000098
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
U.S.$578,361$524,768$1,136,907$1,041,952
Europe46,00737,03385,57569,739
Japan4,3226,46017,02012,017
Total revenues$628,690$568,261$1,239,502$1,123,708

Item 1. Financial Statements.

FAQ

What is Exelixis's europe — total revenues?
Exelixis (EXEL) reported europe — total revenues of $46.01M in Q2 2026.
How has Exelixis's europe — total revenues changed year-over-year?
Exelixis's europe — total revenues increased by 24.2% year-over-year, from $37.03M to $46.01M.
What is the long-term trend for Exelixis's europe — total revenues?
Over 4 years (2021 to 2025), Exelixis's europe — total revenues has grown at a -15.5% compound annual growth rate (CAGR), from $302.07M to $154.17M.
What does europe — total revenues mean?
This metric represents the total gross revenue generated from the sale of pharmaceutical products and licensing agreements within the European geographic market. It captures the financial performance of the company's oncology portfolio in this specific region, reflecting market penetration and commercial success of approved therapies. Fluctuations in this figure often indicate changes in regional regulatory approvals, competitive landscape shifts, or variations in local pricing and reimbursement agreements.

Ask your AI about Exelixis's europe — total revenues.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude